Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinagolide Vaginal Ring for Endometriosis-related Pain
NCT03692403Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Dec 2018
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of quinagolide in endometriosis (4 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Mean Daily Numerical Rating Scale (NRS) Scores for the Worst Endometriosis-related Pain at Cycle 4. Started Dec 2018; status: completed.
02
Drugs
quinagolide
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03692403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03692403.